Affiliation:
1. Central Veterinary Institute, Department of Virology, Lelystad, The Netherlands.
Abstract
A set of monoclonal antibodies was used to isolate nonneutralizable foot-and-mouth disease virus variants, and the RNAs of the variants were sequenced. Cross-neutralization studies and mapping of the amino acid changes indicated two major antigenic sites. The first site was trypsin sensitive and included the VP1 140 to 160 sequence. The second site was trypsin insensitive and included mainly VP3 residues. Two minor sites were located near VP1 169 and on the C terminus of VP1. Comparison with poliovirus type 1 and human rhinovirus 14 showed a similarity in the immunogenicity of comparable sites on the viruses.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference30 articles.
1. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus;Bachrach H. L.;J. Immunol.,1975
2. Neutralising monoclonal antibodies against foot and mouth disease virus (FMDV) are directed towards antigenic sites on VP1, VP2 and VP3;Barteling S. J.;Bull. Off. Int. Epizoot.,1986
3. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination;Beck E.;J. Virol.,1987
4. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence;Bittle J. L.;Nature (London),1982
5. The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus;Boothroyd J. C.;Gene,1982
Cited by
167 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献